PROPIONYL CARNITINE IN STABLE EFFORT ANGINA

被引：16

作者：

CHERCHI, A ^{[1
]}

LAI, C ^{[1
]}

ONNIS, E ^{[1
]}

ORANI, E ^{[1
]}

PIRISI, R ^{[1
]}

PISANO, MR ^{[1
]}

SORO, A ^{[1
]}

CORSI, M ^{[1
]}

机构：

[1] UNIV CAGLIARI,INST CARDIOL,I-09100 CAGLIARI,ITALY

来源：

CARDIOVASCULAR DRUGS AND THERAPY | 1990年 / 4卷 / 02期

关键词：

effort angina; propionyl carnitine;

D O I：

10.1007/BF01857757

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The aim of this study was to investigate the antiischemic activity of propionyl carnitine (PC) in 18 informed, volunteer male patients, aged 37-70, suffering from a typical stable effort angina. The study design was randomized, balanced, crossover, and double blinded. The study lasted 75 days. In the first 15 days of washout the patients performed two maximal symptom-limited bicycle tests to verify the repeatability of the parameters examined. Then one group received PC for 30 days 500 mg three times a day, and the other group received placebo (PL) three times a day. At the end of 30 days the groups exchanged treatments. At the end of each period, 2 hours after the last oral administration, the patients performed a maximal symptom-limited bicycle exercise test with increased loads of 10 watts/min. No significant differences were observed between the two tests performed during the wash-out period, for a 1mm ST-segment depression time, for the time to the end of exercise, and for the rate x pressure product at the same experimental time. The oral administration of PC in coronary patients increased both the 1 mm ST-segment depression time and the time to the end of exercise. Furthermore, the drug reduced the ischemic depression of ST at maximal common work and at maximal work. After PC, the rate x pressure product was not significantly different in relation to placebo at submaximal and maximal exercise. Thus PC seems to have an antiischemiclike effect, probably related to its metabolic activity. © 1990 Kluwer Academic Publishers.

引用

页码：481 / 486

页数：6

共 43 条

[21] Cherchi A., Lai C., Cioglia G., Et al., Influence of carnitine on exercise tolerance test in effort angina pectoris, Proceedings of the IX Congress of Cardiology, Moscow, 1, (1982)
[22] Thoen J.H., Shug A.L., Yap V.U., Et al., Improved pacing tolerance of the ischemic human myocardium after administration of carnitine, Am J Cardiol, 43, pp. 300-306, (1979)
[23] Cherchi A., Lai C., Angelino F., Et al., Effects of L-carnitine on exercise tolerance in chronic stable angina: A multicenter double-blind, randomized, placebo controlled cross over study, Clin Pharm, 23, pp. 569-572, (1985)
[24] Ferrari R., Cucchini F., Dilisa F., Et al., The effect of L-carnitine (carnitene) on myocardial metabolism of patients with coronary artery disease, Clin Trial J, 21, pp. 40-58, (1984)
[25] Kosolcharoen P., Nappi J., Peduzzi P., Et al., Improved exercise tolerance after administration of carnitine, Curr Ther Res, 30, pp. 753-764, (1981)
[26] Kamikawa T., Suzuki Y., Kobayashi A., Et al., Effects of L-carnitine on exercise tolerance in patients with stable angina, Jpn Heart J, 25, pp. 587-597, (1984)
[27] Kotaka K., Miyazaki Y., Ogawa K., Et al., Reversal of ischemia-induced mitochondrial dysfunction after coronary reperfusion, J Mol Cell Cardiol, 14, pp. 223-231, (1982)
[28] Cherchi A., Nissardi G.P., Raffo M., Et al., Electrocardiogramme et metabolisme an course de l'effort chez normaux et les cardiaques: Un test calibrè pour l'evaluation de l'insuffisance coronaire, IV Congr. Mundial de Cardiologia, Mexico, 2, pp. 224-335, (1962)
[29] Cherchi A., Fonzo R., Bina M., Influence of nifedipine on the effort tolerance test in angina pectoris. Comparison with placebo and trinitroglycerine, Giorn It Cardiol, 4, pp. 1-10, (1974)
[30] Rosseau M.F., Hanet C., Pardonge-Lavenne E., Et al., Changes in myocardial metabolism during therapy in patients with chronic stable angina: A comparison of long-term dosing with propranolo and nicardipine, Circulation, 73, pp. 1270-1280, (1986)

← 1 2 3 4 5 →